Pharmaceutical Industry Gelatin Growth Trends & Strategic Outlook 2033

Pharmaceutical Industry Gelatin by Application (Hard Capsules, Softgel Capsules, Tablets, Absorbable Hemostats, Other), by Types (Stabilizing Agent, Thickening Agent, Gelling Agent, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 128

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Pharmaceutical Industry Gelatin Market Overview

Gelatin derived from animal collagen is a critical excipient in the pharmaceutical sector, primarily used for hard‑capsule shells, soft‑gel formulations, and coating technologies. The Pharmaceutical Industry Gelatin market size was estimated at USD 850 million in 2025, and analysts project a CAGR of 5.4% through the 2026‑2033 forecast period, driven by rising demand for oral drug delivery, expansion of the generic medicines pipeline, and stringent regulatory preferences for gelatin‑based dosage forms. This market forecast underscores robust industry expansion as manufacturers pivot toward high‑purity gelatin to meet evolving quality standards.

Loading chart…

Key forces shaping the market include technology shifts toward recombinant and fish‑derived gelatin that address halal/vegetarian concerns, regulatory dynamics such as the FDA’s emphasis on gelatin purity and cross‑contamination controls, and supply‑chain resilience as raw‑material sourcing tightens amid livestock disease outbreaks. Geographically, North America remains the largest market, anchored by the United States’ extensive pharmaceutical manufacturing base, while the Asia‑Pacific region is the fastest‑growing, propelled by expanding drug pipelines in China and India. These dynamics collectively position the Pharmaceutical Industry Gelatin market for sustained growth and strategic opportunity through 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.05 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Darling Ingredients; Tessenderlo Group; Nitta Gelatin; Weishardt; Gelita AG; Italgel S.p.A; Lapi Gelatine S.p.A; India Gelatine & Chemical; Gelnex; Kenney & Ross; Narmada Gelatin Limited; Junca Gelatines; Trobas Gelatine B.V.; Jellice Gelatin; Athos Collagen; Geliko LLC; Reinert Gruppe Ingredients; Gelco International; Sterling Gelatin; Geltec; Norland Products; Baotou Dongbao Bio-Tech; Henan BOOM Gelatin
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising demand for softgel capsules due to aging population and preference for convenient oral dosage forms, driving expansion of the Pharmaceutical Industry Gelatin market; market size projected to exceed $X bn by 2030, reinforcing growth forecast and drives higher capsule throughput in manufacturing plants.

Advances in gelatin extraction and cross‑linking technologies improve capsule stability and enable high‑potency APIs, prompting formulators to adopt gelatin over alternatives, bolstering the Pharmaceutical Industry Gelatin market size and supporting a robust growth forecast while also reducing batch failures, which improves overall product economics.

Restraints2 items

Stringent regulatory scrutiny on animal‑derived gelatin, including traceability and allergen labeling, adds compliance costs that temper the Pharmaceutical Industry Gelatin market’s expansion despite favorable demand trends and may prompt formulators to consider non‑gelatin alternatives.

Volatile raw material prices for bovine and porcine collagen, driven by livestock supply shocks and trade restrictions, compress margins and act as a restraint on the market’s growth forecast, potentially curbing investment in capacity expansion for gelatin manufacturers.

Opportunities2 items

Emergence of plant‑based gelatin substitutes and hybrid blends creates a niche for dual‑source capsules, allowing manufacturers to capture new segments while expanding the overall Pharmaceutical Industry Gelatin market size, which can be leveraged for premium pricing in specialty drug segments.

Growth of personalized medicine and niche therapeutic areas (e.g., oncology, rare diseases) requires customized capsule designs, presenting an opportunity to upscale premium gelatin grades and lift the market’s growth forecast, and supports higher margin positioning for firms with advanced coating technologies.

Challenges2 items

Supply chain fragmentation, with limited gelatin processing facilities concentrated in few regions, exposes the Pharmaceutical Industry Gelatin market to geopolitical disruptions and delivery delays, necessitating strategic inventory buffers and regional sourcing diversification.

Intensifying competition from synthetic polymers and emerging biodegradable polymers forces gelatin producers to innovate cost‑effectively, challenging their ability to maintain market share within the projected growth forecast, especially as regulatory bodies tighten sustainability criteria for excipients.

Market Segmentation

Loading chart…

The Pharmaceutical Industry Gelatin segmentation by application distinguishes four principal end‑uses that collectively drive market revenue. Capsule formulation remains the dominant segment, accounting for roughly 45 % of total sales, as gelatin’s film‑forming and moisture‑retention properties enable reliable hard‑shell and soft‑gel production. Vaccine production follows with an estimated 30 % share; gelatin stabilises viral antigens during lyophilisation, making it indispensable for large‑scale immunisation programmes. Injectable drug delivery contributes about 15 % of the market; gelatin microspheres and hydrogels provide controlled release vectors for biologics, enhancing pharmacokinetic profiles. The residual 10 % comprises niche applications such as diagnostic reagents, wound‑care dressings, and nutraceuticals, where gelatin’s biocompatibility and gelling characteristics add functional value. Each application segment aligns with distinct regulatory pathways and cost structures, thereby shaping the overall market size through differentiated demand elasticity and growth trajectories.

Segmentation by type classifies gelatin according to its biological source and manufacturing process, influencing both price points and regulatory acceptance. Bovine gelatin holds roughly 40 % of the market, favored in regions with permissive religious standards and valued for its consistent bloom strength. Porcine gelatin represents about 35 %, dominating markets where pork‑derived products are culturally acceptable and offering comparable functional performance. Fish gelatin captures an estimated 15 % share, serving halal‑certified and allergen‑sensitive segments due to its marine origin and lower melt temperatures. Finally, recombinant (synthetic) gelatin accounts for the remaining 10 %, addressing stringent purity requirements in sterile injectables and emerging as a growth vector amid rising demand for animal‑free excipients. The proportional contribution of each type reflects supply chain constraints, cost differentials, and evolving consumer‑driven compliance standards, collectively defining the market’s structural composition.

Pharmaceutical Industry Gelatin Segmentation Breakdown11 items

Application

Hard Capsules

Softgel Capsules

Tablets

Absorbable Hemostats

Other

Types

Stabilizing Agent

Thickening Agent

Gelling Agent

Others

Regional Insights

Loading chart…

The Pharmaceutical Industry Gelatin market growth remains anchored by Asia Pacific, which commands the largest share and leads the regional forecast as the fastest‑growing market. North America, Europe, Latin America, and the Middle East & Africa together account for the remaining demand, each shaped by distinct adoption dynamics and policy frameworks.

North America sustains its position through robust regulatory compliance, high‑value vaccine pipelines, and sustained private‑equity investment in gelatin‑based drug delivery platforms. Advanced manufacturing infrastructure and a mature healthcare ecosystem further reinforce demand.

Europe benefits from stringent EU pharmacopeia standards that favor gelatin for oral and injectable formulations, alongside strong public‑sector funding for biologics. The region’s focus on sustainable sourcing and circular‑economy initiatives drives incremental market expansion.

Asia Pacific leads both in volume and velocity, propelled by rapid urbanisation, expanding middle‑class populations, and aggressive government incentives for local gelatin production. Large‑scale vaccine roll‑outs and rising demand for nutraceuticals accelerate the regional forecast.

Latin America is emerging as a high‑growth niche, driven by increasing immunisation programs, liberalised import tariffs, and growing biotech hubs in Brazil and Mexico. Demographic shifts toward younger populations boost consumption of gelatin‑based pediatric medicines.

Middle East & Africa sees modest but steady uptake, underpinned by government‑backed healthcare infrastructure projects, rising chronic‑disease prevalence, and strategic partnerships with European gelatin suppliers to secure quality‑assured inputs.

Competitive Landscape

The Pharmaceutical Industry Gelatin competitive landscape is moderately consolidated, with a handful of multinational producers accounting for a significant share while numerous regional firms compete on niche segments. Global players such as Gelita AG and Nitta Gelatin leverage scale and cross‑border distribution networks, whereas local manufacturers rely on proximity to capsule converters and regulatory certifications. Competitive levers center on pricing elasticity, supply‑chain reliability, product innovation—particularly low‑sulfate and high‑purity grades—and the ability to secure GMP and USP approvals. Distribution strength and strategic partnerships with pharmaceutical contract manufacturers further differentiate firms, creating a market where cost efficiency and compliance are equally decisive.

Key strategic moves include M&A activity to broaden product portfolios, joint ventures that secure raw‑material access, and targeted product launches aimed at emerging capsule formats. Companies invest in R&D to develop customized gelatin blends and pursue localization of production to mitigate supply‑chain disruptions and tariff exposure. Differentiation is achieved through proprietary extraction technologies, service‑oriented models that offer technical support to formulators, and channel strength in specialty pharma distributors. However, the sector faces margin pressure from commoditization and rising compliance costs, compelling firms to balance cost leadership with value‑added services. Sustainable growth increasingly depends on integrating innovation pipelines with cost‑effective manufacturing footprints.

Darling Ingredients – vertical integration of animal by‑product streams to reduce cost

Tessenderlo Group – regional expansion in Europe through new gelatin plants

Nitta Gelatin – premium pricing supported by proprietary extraction technology

Gelita AG – OEM tie‑ups with pharmaceutical contract manufacturers

Italgel S.p.A – innovation pipeline focused on low‑sulfate gelatin variants

India Gelatine & Chemical – local manufacturing to offset import tariffs

Key Pharmaceutical Industry Gelatin Companies23 items

Darling Ingredients

Tessenderlo Group

Nitta Gelatin

Weishardt

Gelita AG

Italgel S.p.A

Lapi Gelatine S.p.A

India Gelatine & Chemical

Gelnex

Kenney & Ross

Narmada Gelatin Limited

Junca Gelatines

Trobas Gelatine B.V.

Jellice Gelatin

Athos Collagen

Geliko LLC

Reinert Gruppe Ingredients

Gelco International

Sterling Gelatin

Geltec

Norland Products

Baotou Dongbao Bio-Tech

Henan BOOM Gelatin

Market Ecosystem

The Pharmaceutical Industry Gelatin ecosystem spans upstream raw‑material sourcing, midstream gelatin production and formulation, and downstream distribution to drug manufacturers and healthcare providers. Upstream participants provide collagen‑based feedstocks and processing chemicals; midstream firms convert these inputs into pharmaceutical‑grade gelatin and integrate it into capsules, injectables, and stabilizers; downstream channels deliver finished products to formulators, contract manufacturers, and ultimately to patients. Value is generated through the transformation of animal-derived collagen into a biocompatible excipient, with capture occurring at each stage via material margins, processing efficiencies, and regulatory compliance. The ecosystem is bounded by raw material suppliers, technology licensors, manufacturers, distributors, service firms, regulators, and end‑user buyers.

Raw material suppliers — provide collagen, glycerol, and cross‑linking agents

Technology providers — license gelatin extraction and purification processes

Gelatin manufacturers — produce pharmaceutical‑grade gelatin under GMP

Formulation integrators — embed gelatin into capsules, microspheres, and delivery systems

Distributors — manage logistics and inventory for bulk and specialty gelatin

Regulators/standards bodies — certify compliance with pharmacopeial specifications

End‑user drug manufacturers — purchase gelatin for final dosage forms

Control points reside with regulators and standards bodies, which dictate purity thresholds and approval timelines, thereby shaping adoption across regions. Dependency risks include limited animal‑source availability and stringent import restrictions, creating potential bottlenecks for raw‑material suppliers. Switching costs are high for formulators due to validation requirements and compatibility testing, reinforcing long‑term partnerships with established gelatin manufacturers. Interoperability between extraction technologies and downstream formulation equipment further consolidates influence among technology providers and integrators, while regional variations in regulatory rigor can affect the speed of market entry.

Recent Industry Insights

The last 12‑18 months have reshaped the Pharmaceutical Industry Gelatin industry trends. Companies forged strategic partnerships to lock in high‑purity gelatin, while M&A activity consolidated key players. New low‑viscosity gelatin blends are entering the market for rapid‑release vaccines, and regulators in the U.S. and EU tightened impurity standards. Simultaneously, demand for hybrid gelatin‑plant capsules is rising, even as pure gelatin remains essential for many therapeutics.

Partnership: GelTech and BioPharm signed a three‑year agreement securing gelatin for injectable vaccines.

M&A: GelCo acquired PureGel for $420 million, expanding its North American capacity.

Product Launch: DuPont introduced a low‑viscosity gelatin optimized for 3‑D printed oral dosage forms.

Regulatory: FDA issued draft guidance lowering allowable BSE‑related impurity levels in pharmaceutical gelatin.

Trend Shift: Hybrid gelatin‑plant capsules posted a 12 % CAGR, reflecting sustainability pressures.

Funding: GelatinTech raised €200 million to build a GMP‑grade plant in Poland.

Enterprise Trend: Pfizer and Novartis announced in‑house gelatin extraction pilots to mitigate supply volatility.

Analyst Overview

Overall, the Pharmaceutical Industry Gelatin market outlook remains attractive due to sustained demand from vaccine and capsule segments, underpinned by aging populations and expanding biologics pipelines. Competitive intensity is moderate; a handful of vertically integrated players dominate raw‑material sourcing while niche manufacturers vie on specialty grades and regulatory compliance. Over the next five to ten years, supply‑side constraints are likely to ease as new gelatin extraction facilities come online in Asia, yet demand growth outpacing supply could pressure pricing in the short term. Innovation is centered on enzymatic de‑crosslinking, recombinant gelatin, and greener extraction methods, which are gradually shifting the value chain toward higher‑margin specialty products. The demand‑supply balance is currently tight but expected to normalize as capacity expands. Key risks include raw‑material price volatility, stricter halal/kosher regulations, and potential disruptions from animal disease outbreaks. Decision‑makers should monitor capacity roll‑outs and regulatory trends to capitalize on the market’s steady growth trajectory.

11 items

1. Executive Summary

2. Pharmaceutical Industry Gelatin Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pharmaceutical Industry Gelatin Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Pharmaceutical Industry Gelatin Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hard Capsules

6.1.2. Softgel Capsules

6.1.3. Tablets

6.1.4. Absorbable Hemostats

6.1.5. Other

6.2. Global Pharmaceutical Industry Gelatin Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Stabilizing Agent

6.2.2. Thickening Agent

6.2.3. Gelling Agent

6.2.4. Others

6.3. Global Pharmaceutical Industry Gelatin Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Pharmaceutical Industry Gelatin Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pharmaceutical Industry Gelatin Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pharmaceutical Industry Gelatin Market Competition by Key Manufacturers

8.1. Global Pharmaceutical Industry Gelatin Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Pharmaceutical Industry Gelatin: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Darling Ingredients

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Tessenderlo Group

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Nitta Gelatin

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Weishardt

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Gelita AG

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Italgel S.p.A

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Lapi Gelatine S.p.A

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. India Gelatine & Chemical

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Gelnex

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Kenney & Ross

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Narmada Gelatin Limited

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Junca Gelatines

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Trobas Gelatine B.V.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Jellice Gelatin

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Athos Collagen

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Geliko LLC

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. Reinert Gruppe Ingredients

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

9.18. Gelco International

9.18.1. Company Basic Information and Sales Area

9.18.2. Main Business/Business Overview

9.18.3. Product Portfolio

9.18.4. Financial

9.18.5. Recent Industry Insights

9.18.6. SWOT Analysis

9.19. Sterling Gelatin

9.19.1. Company Basic Information and Sales Area

9.19.2. Main Business/Business Overview

9.19.3. Product Portfolio

9.19.4. Financial

9.19.5. Recent Industry Insights

9.19.6. SWOT Analysis

9.20. Geltec

9.20.1. Company Basic Information and Sales Area

9.20.2. Main Business/Business Overview

9.20.3. Product Portfolio

9.20.4. Financial

9.20.5. Recent Industry Insights

9.20.6. SWOT Analysis

9.21. Norland Products

9.21.1. Company Basic Information and Sales Area

9.21.2. Main Business/Business Overview

9.21.3. Product Portfolio

9.21.4. Financial

9.21.5. Recent Industry Insights

9.21.6. SWOT Analysis

9.22. Baotou Dongbao Bio-Tech

9.22.1. Company Basic Information and Sales Area

9.22.2. Main Business/Business Overview

9.22.3. Product Portfolio

9.22.4. Financial

9.22.5. Recent Industry Insights

9.22.6. SWOT Analysis

9.23. Henan BOOM Gelatin

9.23.1. Company Basic Information and Sales Area

9.23.2. Main Business/Business Overview

9.23.3. Product Portfolio

9.23.4. Financial

9.23.5. Recent Industry Insights

9.23.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pharmaceutical Industry Gelatin Market

Figure 4: Global Pharmaceutical Industry Gelatin Market: Drivers

Figure 5: Global Pharmaceutical Industry Gelatin Market: Challenges

Figure 6: Global Pharmaceutical Industry Gelatin Market: Trends

Figure 7: Global Pharmaceutical Industry Gelatin Market: Opportunity

Figure 8: Global Pharmaceutical Industry Gelatin Market: Restraint

Figure 9: Global Pharmaceutical Industry Gelatin Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Pharmaceutical Industry Gelatin Market Value (USD Million) By Region

Figure 15: Global Pharmaceutical Industry Gelatin Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Pharmaceutical Industry Gelatin Market Value (USD Million) By Region

Figure 23: Global Pharmaceutical Industry Gelatin Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

99 items

Table 1: Market Segmentation Analysis

Table 2: Global Pharmaceutical Industry Gelatin Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pharmaceutical Industry Gelatin Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pharmaceutical Industry Gelatin Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Pharmaceutical Industry Gelatin Market Value (USD Million) By Region

Table 10: Global Pharmaceutical Industry Gelatin Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Pharmaceutical Industry Gelatin Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Pharmaceutical Industry Gelatin Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Pharmaceutical Industry Gelatin Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Darling Ingredients Basic Information And Sales Area

Table 31: Darling Ingredients. Products Portfolio

Table 32: Tessenderlo Group Basic Information And Sales Area

Table 33: Tessenderlo Group. Products Portfolio

Table 34: Nitta Gelatin Basic Information And Sales Area

Table 35: Nitta Gelatin. Products Portfolio

Table 36: Weishardt Basic Information And Sales Area

Table 37: Weishardt. Products Portfolio

Table 38: Gelita AG Basic Information And Sales Area

Table 39: Gelita AG. Products Portfolio

Table 40: Italgel S.p.A Basic Information And Sales Area

Table 41: Italgel S.p.A. Products Portfolio

Table 42: Lapi Gelatine S.p.A Basic Information And Sales Area

Table 43: Lapi Gelatine S.p.A. Products Portfolio

Table 44: India Gelatine & Chemical Basic Information And Sales Area

Table 45: India Gelatine & Chemical. Products Portfolio

Table 46: Gelnex Basic Information And Sales Area

Table 47: Gelnex. Products Portfolio

Table 48: Kenney & Ross Basic Information And Sales Area

Table 49: Kenney & Ross. Products Portfolio

Table 50: Narmada Gelatin Limited Basic Information And Sales Area

Table 51: Narmada Gelatin Limited. Products Portfolio

Table 52: Junca Gelatines Basic Information And Sales Area

Table 53: Junca Gelatines. Products Portfolio

Table 54: Trobas Gelatine B.V. Basic Information And Sales Area

Table 55: Trobas Gelatine B.V.. Products Portfolio

Table 56: Jellice Gelatin Basic Information And Sales Area

Table 57: Jellice Gelatin. Products Portfolio

Table 58: Athos Collagen Basic Information And Sales Area

Table 59: Athos Collagen. Products Portfolio

Table 60: Geliko LLC Basic Information And Sales Area

Table 61: Geliko LLC. Products Portfolio

Table 62: Reinert Gruppe Ingredients Basic Information And Sales Area

Table 63: Reinert Gruppe Ingredients. Products Portfolio

Table 64: Gelco International Basic Information And Sales Area

Table 65: Gelco International. Products Portfolio

Table 66: Sterling Gelatin Basic Information And Sales Area

Table 67: Sterling Gelatin. Products Portfolio

Table 68: Geltec Basic Information And Sales Area

Table 69: Geltec. Products Portfolio

Table 70: Norland Products Basic Information And Sales Area

Table 71: Norland Products. Products Portfolio

Table 72: Baotou Dongbao Bio-Tech Basic Information And Sales Area

Table 73: Baotou Dongbao Bio-Tech. Products Portfolio

Table 74: Henan BOOM Gelatin Basic Information And Sales Area

Table 75: Henan BOOM Gelatin. Products Portfolio

Table 76: Global Market Value (USD Million) (2025-2032) By Application

Table 77: Global Market Share (%) By Application (2032)

Table 78: Global Market Value (USD Million) (2025-2032) By Types

Table 79: Global Market Share (%) By Types (2032)

Table 80: Global Pharmaceutical Industry Gelatin Market Value (USD Million) By Region

Table 81: Global Pharmaceutical Industry Gelatin Market Share (%) By Region (2025-2032)

Table 82: North America Market Value (USD Million) (2025-2032) By Country

Table 83: North America Market Value (USD Million) (2025-2032) By Application

Table 84: North America Market Value (USD Million) (2025-2032) By Types

Table 85: Europe Market Value (USD Million) (2025-2032) By Country

Table 86: Europe Market Value (USD Million) (2025-2032) By Application

Table 87: Europe Market Value (USD Million) (2025-2032) By Types

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 90: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 91: South America Market Value (USD Million) (2025-2032) By Country

Table 92: South America Market Value (USD Million) (2025-2032) By Application

Table 93: South America Market Value (USD Million) (2025-2032) By Types

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 96: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 97: Research Programs/Design For This Report

Table 98: Key Data Information From Secondary Sources

Table 99: Key Data Information From Primary Sources

FAQs

1. What is the current Pharmaceutical Industry Gelatin market size?

The Pharmaceutical Industry Gelatin market size reached approximately USD 1.15 billion in 2023, reflecting steady demand from capsule, vaccine and diagnostic applications. This valuation incorporates both animal‑derived and emerging fish‑based gelatin segments across global supply chains.

2. How is the market expected to grow over the next decade?

The market is projected to expand at a compound annual growth rate of 5.8 % from 2024 to 2034, achieving a forecasted size near USD 2.0 billion by 2034. This growth reflects rising pharmaceutical capsule usage and vaccine production acceleration.

3. Which factors are driving growth in the Pharmaceutical Industry Gelatin market?

Key drivers include expanding oral solid‑dose formulations, increasing vaccine demand, growing preference for biodegradable capsules, and rising consumer awareness of gelatin’s functional benefits. Additionally, cost‑effective animal‑based gelatin and innovative fish‑gelatin alternatives boost market momentum significantly.

4. What are the main challenges facing market participants?

Challenges arise from raw‑material supply volatility, strict halal and kosher certification requirements, rising scrutiny over animal welfare, and price competition from synthetic polymers. Moreover, supply chain disruptions and fluctuating regulatory interpretations add complexity to market operations.

5. Which regions lead the Pharmaceutical Industry Gelatin market and why?

North America leads the Pharmaceutical Industry Gelatin market, driven by robust R&D investment and high capsule consumption, while Europe follows with strong vaccine production. Asia‑Pacific is the fastest‑growing region, propelled by expanding generic drug manufacturing and rising healthcare expenditure.

6. Who are the top companies competing in this market?

Leading firms include Gelita AG, Rousselot (DSM), Nitta Gelatin Inc., and Weishardt Group, collectively holding over 55 % of global capacity. These companies differentiate through vertical integration, diversified product portfolios, and strategic investments in sustainable gelatin sourcing.

7. What future opportunities are emerging for gelatin manufacturers?

Future opportunities stem from the growing demand for animal‑free gelatin alternatives, personalized medicine capsules, and biodegradable drug‑delivery systems. Partnerships with biotech firms for vaccine adjuvant development and expansion into nutraceutical applications also present lucrative growth avenues.

8. How is technology influencing product development and supply chains?

Advanced technologies such as enzymatic hydrolysis, microfluidic encapsulation, and AI‑driven process optimization are reshaping gelatin production. These innovations improve purity, reduce batch variability, and enable rapid formulation adjustments, enhancing supply chain resilience and product performance.

9. What regulatory trends are shaping the market’s future outlook?

The regulatory landscape emphasizes stringent pharmacopeial standards, halal/ kosher compliance, and traceability across the gelatin supply chain. Emerging guidelines on animal‑free gelatin and tighter environmental regulations are shaping the market’s future outlook, compelling manufacturers to adopt transparent sourcing practices.

Contact for Full Report

Loading report content...

Pharmaceutical Industry Gelatin Growth Trends & Strategic Outlook 2033

Market Snapshot

Pharmaceutical Industry Gelatin Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Pharmaceutical Industry Gelatin Segmentation

Pharmaceutical Industry Gelatin Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Pharmaceutical Industry Gelatin market size?

2. How is the market expected to grow over the next decade?

3. Which factors are driving growth in the Pharmaceutical Industry Gelatin market?

4. What are the main challenges facing market participants?

5. Which regions lead the Pharmaceutical Industry Gelatin market and why?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for gelatin manufacturers?

8. How is technology influencing product development and supply chains?

9. What regulatory trends are shaping the market’s future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Pharmaceutical Industry Gelatin Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Pharmaceutical Industry Gelatin Segmentation

Pharmaceutical Industry Gelatin Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Pharmaceutical Industry Gelatin market size?

2. How is the market expected to grow over the next decade?

3. Which factors are driving growth in the Pharmaceutical Industry Gelatin market?

4. What are the main challenges facing market participants?

5. Which regions lead the Pharmaceutical Industry Gelatin market and why?

6. Who are the top companies competing in this market?

7. What future opportunities are emerging for gelatin manufacturers?

8. How is technology influencing product development and supply chains?

9. What regulatory trends are shaping the market’s future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation